Portfolio of Research
Current diseases and targets we are exploring.
GRA
Funding
Funding
CEO
Dr. Hajduk is a founder and brings 45 years experience in human innate immunity. He provides vision for Annate's future.
President
Dr. DeJesus asked the initial questions which led to starting Annate and currently leads the growth of the company into new areas.
Vice President
Dr. Cipriano leads the research and development of Annate's unique technology.
Annate BiTherapeutics Inc. founders formed the company in 2021 to bring to market our unique technology.